bullish

Biopharma Week in Review - November 11, 2024

121 Views13 Nov 2024 19:44
Issuer-paid
We review last week’s biopharma news for meaningful clinical data, regulatory updates, research innovation, and M&A. Last week, election headlines and earnings dominated the news cycle.
What is covered in the Full Insight:
  • Introduction to Biopharma Week in Review
  • Political Impact on Biopharma
  • Clinical Updates and M&A
  • Company Highlights: Viking, AstraZeneca, Corbus
  • Detailed Performance of Specific Drugs
SUMMARY
(Sign Up to Access)
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
  • Unlock research summaries
  • Follow top, independent analysts
  • Receive personalised alerts
  • Access Analytics, Events and more

Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.

Upgrade later to our paid plans for full-access.

or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 7-minute read)
Discussions
(Paid Plans Only)
chart-bar
Logo
Water Tower Research
Research from Water Tower Research
Water Tower Research
Equity Bottom-UpThematic (Sector/Industry)
  • Loading...
x